Findings from a recent study suggest iron deficiency anemia (IDA) independently and significantly increases the odds of ...

BioMarin has followed through on its shift to external innovation, inking a deal to buy Inozyme for $270 million to add a phase 3 enzyme replacement therapy to its pipeline.

Beginning this fall, the state’s new literacy plan aims to boost early reading skills through literacy screenings, ...